September 25, 2012

A recent breakthrough in nanotechnology could lead to a three-million-fold improvement in the early detection of diseases such as cancer and Alzheimer’s disease. According to scientific journals Nanotechnology and Analytical Chemistry, the technology would enable doctors to detect the lowest concentration of telltale markers of a disease, allowing for earliest possible detection and intervention.

Additionally, the new test would be very easy to use, as it would involve the same steps as a common biological test called an immunoassay, according to Princeton engineering professor Stephen Chou.

Read more about this potential new test system in this article.